Recent Posts

Sanofi-Aventis Settles 3 Lawsuits Over Eloxatin
Posted on 1 Apr 2010 by LexisNexis Litigation Resource Community Staff

PARIS – (AP) Sanofi-Aventis has settled three patent infringement lawsuits in the U.S. related to generic versions of colon cancer treatment Eloxatin, the French drug maker said Thursday. Under terms of the settlements, the three generic drug makers... Read More